Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results

    NEXT STORY
    Axsome Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
    PREV STORY
    Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

    FIT Biotech Oy Company release January 18, 2019 at 04:00 PM EET Conversion of ...

    author_avatar
    NASDAQ Market News

    SELLAS Receives IMPD Approval from the French Regulatory Authority for its Pivotal Phase 3 REGAL Study of Galinpepimut-S in Patients with Acute Myeloid Leukemia

    author_avatar
    NASDAQ Market News

    Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets

    Summit Therapeutics plc  (‘Summit’ or the ’Company’)Summit Discovers Multiple New Mechanism Antibiotics Against Novel ...

    author_avatar
    NASDAQ Market News